GOLDEN ARTHUR F 4

What Happened
Arthur F. Golden, a director of Turn Therapeutics (TTRX), reported a gift of 300,000 common shares on April 2, 2026. The Form 4 shows the transaction code G (gift) and lists the acquisition price as $0.00 (i.e., a non‑cash transfer). This is not a purchase or sale; gifts are transfers and do not necessarily signal insider market sentiment.

Key Details

• Transaction date: 2026-04-02 (reported on Form 4 filed 2026-04-03).
• Transaction type/code: Gift (G). Reported price/value on Form 4: $0.00.
• Shares transferred: 300,000 common shares.
• Shares owned following the transaction: Not disclosed in the provided filing data.
• Footnotes/plan: No 10b5-1 plan, tax‑withholding, or other footnotes were provided in the supplied details.
• Timeliness: Filing appears timely (filed the business day after the transaction).

Context

• Gifts are transfers for estate planning, family, or charitable purposes and do not necessarily indicate the insider’s view on the company’s prospects.
• The Form 4 reports the transfer but does not assign a market dollar value to the gift; secondary sources (e.g., closing stock price) would be needed to estimate fair‑market value.
• The filing does not indicate 10% owner status or that the shares were part of an option exercise or sale.